The Valley Desk

Clinical trial reportAnnals of internal medicinePublished

A Risk Profile Using Simple Hematologic Parameters to Assess Benefits From Baricitinib in Patients Hospitalized With COVID-19: A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-2

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
Annals of internal medicine
Published
Subject terms
Humans; Sulfonamides; Azetidines; Pyrazoles; Purines; Immunologic Factors; Antiviral Agents; Treatment Outcome; Double-Blind Method; Adult; COVID-19; SARS-CoV-2
PubMed ID
38408357
PubMed Central ID
PMC11595704
Added to directory
Source checked

Report a correction or request removal